$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How much will Pemetinib cost after medical insurance reimburses it in 2024, and what are the reimbursement conditions?
2026-02-01 22:25:32
Check Details
Lucius version of crizotinib (crizotinib) generic drug latest price and purchasing precautions
2026-02-01 22:25:32
Check Details
Crizotinib (Crizotinib) Medical Insurance Updates and Generic Drug Price Overview
2026-02-01 22:25:32
Check Details
Detailed explanation of the price, medical insurance situation and purchasing channels of the new anti-cancer drug Crizotinib
2026-02-01 22:25:32
Check Details
Detailed explanation of the usage and precautions of Crizotinib for lung cancer
2026-02-01 22:25:32
Check Details
Crizotinib (Crizotinib) Lao version latest price and buying guide
2026-02-01 22:25:32
Check Details
Lynparza/Olaparib/Cediranib misses survival endpoint in recurrent ovarian cancer trial
2026-02-01 22:25:32
Check Details
FDA approves olaparib/olaparib/abiraterone for companion diagnosis of BRCA+mCRPC
2026-02-01 22:25:32
Check Details
Application and effect of olaparib/olaparib in the treatment of triple-negative breast cancer
2026-02-01 22:25:32
Check Details
Lynparib/olaparib: anticancer efficacy and potential risks
2026-02-01 22:25:32
Check Details
Olaparib vs. Lynparib: Different names for the same drug
2026-02-01 22:25:32
Check Details
Is Lynparib/Olaparib tablets an over-the-counter drug?
2026-02-01 22:25:32
Check Details
1
2
...
1119
1120
1121
1122
1123
1124
1125
...
10239
10240
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Binimetinib + Encorafenib: Dual MEK/BRAF Targeting in BRAF+ Tumors
2
Neratinib Dosing: 240mg Start, Diarrhea Prophylaxis, Hepatic Adjustment
3
Pomalidomide vs Thalidomide: IMiD Generation Gap and MM Use
4
Dasatinib: A BCR-ABL Targeted TKI, Not Conventional Chemo
5
Obeticholic Acid (OCA): FXR Therapy in PBC and Liver Safety Limits
6
Selumetinib and KRAS Mutations: Where the MEK Inhibitor Actually Fits
7
Erdafitinib in Lung Squamous Cell Carcinoma: Indication Boundaries and FGFR Interpretation
8
Eltrombopag: TPO-Receptor Agonist in ITP and Severe Aplastic Anemia
9
Ganaxolone for CDKL5-Related Seizures: GABA-A Modulation, Not a Cure
10
Daraxonrasib (Rasonque): Chemical Identity and RAS Tri-Complex Mechanism
11
Vosoritide Slowing Effect: Not Always Resistance—Check Dose, Adherence, Epiphyses
12
Ramosetron ODT for IBS-D: Gender-Based Dosing and Treatment Review